MARKET

LNTH

LNTH

Lantheus Holding
NASDAQ
66.55
-0.61
-0.91%
After Hours: 66.59 +0.04 +0.06% 18:34 12/31 EST
OPEN
66.94
PREV CLOSE
67.16
HIGH
67.34
LOW
66.36
VOLUME
633.61K
TURNOVER
--
52 WEEK HIGH
111.29
52 WEEK LOW
47.25
MARKET CAP
4.41B
P/E (TTM)
27.95
1D
5D
1M
3M
1Y
5Y
1D
LANTHEUS HOLDINGS INC <LNTH.O>: TD COWEN RAISES TARGET PRICE TO $80 FROM $70
Reuters · 12/30/2025 16:31
TD Cowen Keeps Their Buy Rating on Lantheus (LNTH)
TipRanks · 12/30/2025 16:15
U.S. RESEARCH ROUNDUP-Citigroup, DigitalBridge, Verisk Analytics
Reuters · 12/30/2025 06:38
Weekly Report: what happened at LNTH last week (1222-1226)?
Weekly Report · 12/29/2025 09:31
Lantheus Exit: $28 Million Sale Comes as Earnings Fall 77% Year Over Year
NASDAQ · 12/23/2025 23:45
Solventum is the top performing healthcare supplies stock YTD
Seeking Alpha · 12/22/2025 18:07
Weekly Report: what happened at LNTH last week (1215-1219)?
Weekly Report · 12/22/2025 09:31
Lifeward chairman Joseph Turk to depart, Lantheus CFO Bob Marshall to succeed
TipRanks · 12/19/2025 21:15
More
About LNTH
Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Webull offers Lantheus Holdings Inc stock information, including NASDAQ: LNTH real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNTH stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LNTH stock methods without spending real money on the virtual paper trading platform.